South Shore Capital Advisors Acquires New Shares in SPDR S&P Biotech ETF $XBI

South Shore Capital Advisors acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 4,500 shares of the exchange traded fund’s stock, valued at approximately $549,000.

Other institutional investors also recently modified their holdings of the company. Compass Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at $1,167,000. China Universal Asset Management Co. Ltd. boosted its position in SPDR S&P Biotech ETF by 868.3% in the third quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after purchasing an additional 4,411 shares during the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in SPDR S&P Biotech ETF in the third quarter worth about $417,000. Altfest L J & Co. Inc. boosted its position in SPDR S&P Biotech ETF by 63.1% in the third quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after purchasing an additional 48,326 shares during the last quarter. Finally, Brian Low Financial Group LLC purchased a new position in SPDR S&P Biotech ETF in the third quarter worth about $668,000.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $128.80 on Tuesday. The stock has a market capitalization of $7.50 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The stock’s 50-day simple moving average is $125.01 and its two-hundred day simple moving average is $118.78. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.